Budding CDMO Avara Pharmaceutical Services has bought a solid dose facility in France from AstraZeneca, its third plant acquisition in three months.
AmerisourceBergen has pled guilty and agreed to pay $260 million to settle a federal case over its sales of cancer meds from an unregistered facility.
Generic API maker Cambrex said it will begin a $3.5 million project to improve wastewater processing capabilities at its facility in Sweden.
GlaxoSmithKline has a deal to sell a consumer health products plant in the U.S. to CDMO Avara Pharmaceutical Services.
Fresenius Kabi, which has been spending heavily to broaden its capabilities, has started construction on a $250 million project in Illinois.
Roche has struck a deal to unload a plant in Spain to Recipharm, a move that will save 200 jobs as it sheds unneeded small-molecule facilities.
Zydus Cadila, an Indian injectables maker, said it reached a deal with Russia’s Pharm Aid to manufacture its varicella vaccine for the Russian Federation.
Japanese CDMO Ajinomoto Althea is expanding production at its recently completed high-potency products manufacturing facility in San Diego.
Catalent has agreed to pay $950 million to buy Cook Pharmica and its extensive biologics manufacturing operation in Bloomington, Indiana.
Japan's Fujifilm Diosynth Biotechnologies has completed a $9 million expansion project of its cell manufacturing facilities in the U.K.